Alchemab Therapeutics

Company Deals

Alchemab Therapeutics Licenses ATLX-1282 to Eli Lilly for ALS Treatment

Fineline Cube May 7, 2025

UK-based biotech Alchemab Therapeutics Ltd entered into a licensing agreement with US major Eli Lilly...

Company Deals

Alchemab Therapeutics Partners with Eli Lilly to Discover ALS Treatments

Fineline Cube Jan 10, 2025

UK-based Alchemab Therapeutics has formed a strategic partnership with US major Eli Lilly & Co....

Company Drug

Zhifei Bio Initiates Phase I Study for DTaP-Hib Quadrivalent Vaccine – Component Combination Targets Pediatric Immunization Compliance

Company Drug

Changchun High-Tech Wins FDA Orphan Drug Designation for GenSci128 – TP53 Y220C Reactivator Targets Gastric Cancer

Policy / Regulatory

China NHC Elevates Chikungunya and SFTS to Category B Status – Enhanced Surveillance and Control Measures Effective April 2026

Company Drug

Gan & Lee’s Bonfaglutide Wins NMPA Approval for OSA Study – Biweekly GLP‑1 Expands to Sleep Apnea Indication